中药治疗化疗后癌因性疲乏有效性及安全性的Meta分析
2024-05-21陈琳俪张阿润卜文璐赵欣然刘传波孙韬
陈琳俪 张阿润 卜文璐 赵欣然 刘传波 孙韬



*基金項目:首都卫生发展科研专项项目(2022-2-1023);北京中医药十四五重点专科项目(BJZKBC0003);国家重点研发计划(2018YFC1705100)
第一作者简介:陈琳俪(1997-),女,硕士研究生,研究方向:中西医结合治疗肿瘤学研究。
△通信作者:刘传波,E-mail:Lcb4820@163.com
(1.北京中医药大学第二临床医学院,北京 100029;2.北京中医药大学东方医院,北京 100078)
摘要:目的 系统评价口服中药对癌症患者化疗后癌因性疲乏的疗效与安全性。方法 全面检索有关口服中药治疗癌症患者化疗后癌因性疲乏的临床研究,使用(ROB2)风险评估工具对纳入的文献进行质量评价,使用Stata15软件进行Meta分析。结果 共纳入30篇文献,合并分析结果显示口服中药联合化疗治疗化疗后癌因性疲乏更有效[RR=1.59,95%CI=(1.40-1.80),P<0.01)];Piper评分更低:[SMD=-1.98,CI=(-2.60,-1.36),P<0.01];生活质量更高[SMD=2.04,95%CI=(1.09,2.98),P<0.01]。安全性分析发现,口服中药联合化疗治疗不良反应发生率更低,[RR=0.57,95%CI=(0.48,0.67),P<0.01)]。结论 结果表明,口服中药联合化疗与单一治疗相比,可以显著的改善癌症患者癌因性疲乏的各种结局指标,说明口服中药治疗癌症患者化疗后癌因性疲乏具有其临床价值。
关键词:癌因性疲乏;化疗;口服中药;系统评价;meta分析
中图分类号:R730.5 文献标志码:A 文章编号:1007-2349(2024)05-0031-09
Meta-analysis of Effectiveness and Safety of Traditional Chinese Medicinein the Treatment of Cancer-Related Fatigue after Chemotherapy
CHEN Lin-li1, ZHANG A-run1, BU Wen-lu1, ZHAO Xin-ran1, LIU Chuan-bo2, SUN Tao2
(1. The Second Clinical School of Beijing University of Chinese Medicine, Beijing 100029, China;2. Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China)
【Abstract】Objective: To systematically evaluate the effectiveness and safety of oral Chinese medicine on cancer-related fatigue after chemotherapy in cancer patients. Methods: Clinical studies related to oral Chinese medicine treatment of cancer patients with cancer-related fatigue after chemotherapy were comprehensively searched. The quality of included literature was evaluated using (ROB2) risk assessment tool, and meta-analysis was performed using Stata15 software. Results: A total of 30 literature were included. The combined analysis showed that oral Chinese medicine combined with chemotherapy was more effective in treating cancer-related fatigue after chemotherapy [RR=1.59, 95%CI=(1.40-1.80), P<0.01]. Piper score was lower, [SMD=-1.98, CI= (-2.60, -1.36), P<0.01]. Quality of life was higher, [SMD=2.04, 95%CI=(1.09, 2.98), P<0.01]. Safety analysis showed that oral Chinese medicine combined with chemotherapy had a lower incidence of adverse reactions [RR=0.57, 95%CI=(0.48, 0.67), P<0.01)]. Conclusion: The results show that oral Chinese medicine combined with chemotherapy can significantly improve various outcome indexes of cancer-related fatigue in cancer patients when compared with single therapy, indicating that oral Chinese medicine has its clinical value in treating cancer-related fatigue after chemotherapy.
【Key words】Cancer-Related Fatigue; Chemotherapy; Oral Chinese Medicine; Systematic Evaluation; Meta-Analysis
癌因性疲乏(cancer related fatigue,CRF)是癌癥患者在抗肿瘤治疗中,特别是化疗后最常见的一种不良反应。它与肿瘤本身及其治疗有关,存在于肿瘤发生、发展及治疗的全过程中。美国国立综合癌症网络将CRF定义为“由癌症或癌症治疗引起持续存在的、痛苦的、与身体、情感和/或认知有关的疲劳感或精力衰竭感,与运动量不相关,并干扰日常功能”[1]。与正常的疲乏表现不同的是,CRF持续的时间更长,更痛苦,疲劳感经充足的睡眠及休息后仍难以缓解。CRF是癌症患者常见的症状,一项包含129项研究共71568例患者的荟萃分析指出CRF的患病率达49%[3],而接受化疗和(或)放疗治疗的癌症患者,CRF的发病率高达80%[4]。……
